The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis
Open accessAbstract
Objectives This study sought to perform a systematic review and meta-analysis to understand the prognostic value of myocardial scarring as evidenced by late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) in patients with known or suspected cardiac sarcoidosis. Background Although CMR is increasingly used for the diagnosis of cardiac sarcoidosis, the prognostic value of CMR has been less well described in this population. Methods PubMed, Cochrane CENTRAL, and meta-Register of Controlled Trials were searched for CMR studies with ≥ 1 year of prognostic data. Primary end-points were all-cause mortality and a composite outcome of arrhythmogenic events (ventricular arrhythmia, ICD shock, sudden cardiac death) plus all-cause mortality during follow-up. Summary effect estimates were generated with random-effects modeling. Results Ten studies were included, involving a total of 760 patients with a mean follow up of 3.0 ± 1.1 years. Patients had a mean age of 53 years, 41% were male, 95.3% had known extra-cardiac sarcoidosis, and 21.6% had known cardiac sarcoidosis. The average ejection fraction was 57.8 ± 9.1%. Patients with late gadolinium enhancement had higher odds for all-cause mortality (odds ratio [OR]: 3.06, p < 0.03) and higher odds of the composite outcome (OR: 10.74, p< .00001) compared to those without LGE. Patients with LGE had an increased annualized event rate of the composite outcome (11.9% v. 1.1%; p<0.0001) Conclusions In patients with known or suspected cardiac sarcoidosis, the presence of late gadolinium enhancement on cardiac MRI is associated with increased odds of both all-cause mortality and arrhythmogenic events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roberts, W. C., McAllister, H. A., & Ferrans, V. J. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90121-8 · Cited by 789
Cited by
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000548 · Cited by 412
Nielsen, J. C., Lin, Y.-J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., Dagres, N., Di Toro, D., Eckhardt, L. L., Ellenbogen, K., et al. (2020) · EP Europace · doi:10.1093/europace/euaa065 · Cited by 98
Gilotra, N. A., GRIFFIN, J. M., PAVLOVIC, N., HOUSTON, B. A., CHASLER, J., GOETZ, C., CHRISPIN, J., SHARP, M., KASPER, E. K., CHEN, E. S., et al. (2022) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.06.016 · Cited by 94
Nordenswan, H., Lehtonen, J., Ekström, K., Räisänen‐Sokolowski, A., Mäyränpää, M. I., Vihinen, T., Miettinen, H., Kaikkonen, K., Haataja, P., Kerola, T., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019415 · Cited by 62
Cheng, C.-Y., Baritussio, A., Giordani, A. S., Iliceto, S., Marcolongo, R., & Caforio, A. L. P. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103037 · Cited by 56
Metadata
- Authors
- Coleman, G. C., Shaw, P. W., Balfour, P. C., Gonzalez, J. A., Kramer, C. M., Patel, A. R., & Salerno, M.
- Venue
- JACC: Cardiovascular Imaging
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 10
- Issue
- 4
- Pages
- 411-420
- ISSN
- 1876-7591 (ISSN-L)
- 1936-878X
- OpenAlex
- W2499309551
- Cited by
- 243
- References
- 1
- FWCI
- 15.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis. https://app.cochat.ai/papers/10.1016/j.jcmg.2016.05.009
- The paper
- Coleman, G. C., Shaw, P. W., Balfour, P. C., Gonzalez, J. A., Kramer, C. M., Patel, A. R., & Salerno, M. (2017). Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis. JACC: Cardiovascular Imaging. https://doi.org/10.1016/j.jcmg.2016.05.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
